Publications citing Assaypro: Human Prealbumin (Transthyretin, TTR) ELISA Kit... (36 results)
Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.CRISPRCas3-based editing for targeted deletions in a mouse model of transthyretin amyloidosis
CRISPR-Cas3-based editing for targeted deletions in a mouse model of transthyretin amyloidosis.
Sequential emergence and contraction of epithelial subtypes in the prenatal human choroid plexus revealed by a stem cell model
Sequential emergence and contraction of epithelial subtypes in the prenatal human choroid plexus revealed by a stem cell model.
Investigating the mysteries of human choroid plexus development in varying physiological states using pluripotent stem cells
The Relationship of Plasma Transthyretin Level with Global or Regional Amyloid Beta Burden in Subjects with Amnestic Mild Cognitive Impairment: Cross-Sectional Amyloid PET Study
TTR exon-humanized mouse optimal for verifying new therapies for FAP.
Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia
Discovery of SERPINA3 as a candidate urinary biomarker of lupus nephritis activity
RETRACTED ARTICLE: Impact of maternal nutrition in hepatitis E infection in pregnancy
siRNA Therapy for Transthyretin (TTR) Related Ocular Amyloidosis
Impact of maternal nutrition in hepatitis E infection in pregnancy.
RNAI AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES
Schwann cells contribute to neurodegeneration in transthyretin amyloidosis.
Plasma concentrations of transthyretin in older Sardinians including centenarians
Neuropsychological and plasma biomarkers for detecting Alzheimer's disease
Identification of biomarkers for radiation-induced acute intestinal symptoms (RIAISs) in cervical cancer patients by serum protein profiling
Transthyretin as a novel candidate biomarker for preeclampsia
Identification of new pathogenic candidates for diabetic macular edema using fluorescence-based difference gel electrophoresis analysis
Clinical and biological markers of progression in Alzheimer?s disease
Plasma transthyretin as a candidate marker for Alzheimer's disease
Identification of Novel Fluid Biomarkers for Alzheimer's Disease
Compositions and methods for inhibiting expression of transthyretin
Plasma Transthyretin as a Candidate Marker for Alzheimer's Disease
Are serum protein biomarkers derived from proteomic analysis useful in screening for trisomy 21 at 1113 weeks?
Mir 204, mir 211, their anti-mirs, and therapeutic uses of same
Lipid formulated compositions and methods for inhibiting expression of transthyretin (TTR)
Are Serum Protein Biomarkers Derived from Proteomic Analysis Useful in Screening for Trisomy 21 at 11-13 Weeks?
siRNA therapy for transthyretin (ttr) related ocular amyloidosis
MicroRNA-204/211 alters epithelial physiology
Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease
MicroRNA-204/211 alters epithelial physiology
Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barr? syndrome and other neurological disorders
Developmental Changes in Circulating IL-8/CXCL8 isoforms in Neonates
Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barré syndrome and other neurological disorders
Posttranslational Modifications of Transthyretin Are Serum Markers in Patients with Mycosis Fungoides1